Literature DB >> 22807004

Informed deferral: a moral requirement for entry into the hepatitis C virus treatment warehouse.

Andrew Aronsohn, Donald Jensen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22807004     DOI： 10.1002/hep.25957

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  6 in total

Review 1.  Treatment decisions and contemporary versus pending treatments for hepatitis C.

Authors:  Paul M Trembling; Sudeep Tanwar; William M Rosenberg; Geoffrey M Dusheiko
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-10       Impact factor: 46.802

2.  The changing burden of hepatitis C virus infection in the United States: model-based predictions.

Authors:  Mina Kabiri; Alison B Jazwinski; Mark S Roberts; Andrew J Schaefer; Jagpreet Chhatwal
Journal:  Ann Intern Med       Date:  2014-08-05       Impact factor: 25.391

3.  Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease.

Authors:  S C Gordon; F M Hamzeh; P J Pockros; R S Hoop; A R Buikema; E J Korner; N A Terrault
Journal:  Aliment Pharmacol Ther       Date:  2013-08-25       Impact factor: 8.171

4.  Watchful waiting: role of disease progression on uncertainty and depressive symptoms in patients with chronic hepatitis C.

Authors:  J P Colagreco; D E Bailey; J J Fitzpatrick; C M Musil; N H Afdhal; M Lai
Journal:  J Viral Hepat       Date:  2013-11-07       Impact factor: 3.728

5.  Trends in hepatitis C treatment initiation among HIV/hepatitis C virus-coinfected men engaged in primary care in a multisite community health centre in Maryland: a retrospective cohort study.

Authors:  Yun-Chi Chen; Chloe L Thio; Andrea L Cox; Sebastian Ruhs; Farin Kamangar; Kjell J Wiberg
Journal:  BMJ Open       Date:  2019-03-30       Impact factor: 2.692

Review 6.  Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?

Authors:  Salvatore Petta; Antonio Craxì
Journal:  BMC Infect Dis       Date:  2012-11-12       Impact factor: 3.090
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.